{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:34:03Z","timestamp":1782398043953,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Depression (Dep) is one of the most common concomitant symptoms of Parkinson's disease (PD), but there is a lack of detailed pathologic evidence for the occurrence of PD-Dep. Currently, the management of symptoms from both conditions using conventional pharmacological interventions remains a formidable task. In this study, we found impaired activation of extracellular signal-related kinase (ERK), reduced levels of transcription and translation, and decreased expression of brain-derived neurotrophic factor (BDNF) in the medial prefrontal cortex (mPFC) of PD-Dep rats. We demonstrated that the abnormal phosphorylation of \u03b1-synuclein (pS129) induced tropomyosin-related kinase receptor type B (TrkB) retention at the neuronal cell membrane, leading to BDNF\/TrkB signaling dysfunction. We chose SEW2871 as an ameliorator to upregulate ERK phosphorylation. The results showed that PD-Dep rats exhibited improvement in behavioral manifestations of PD and depression. In addition, a reduction in pS129 was accompanied by a restoration of the function of the BDNF\/ERK signaling loop in the mPFC of PD-Dep rats.<\/jats:p>","DOI":"10.1007\/s12264-024-01323-x","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T16:07:02Z","timestamp":1732810022000},"page":"951-969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Alpha-synuclein Fibrils Inhibit Activation of the BDNF\/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression"],"prefix":"10.1007","volume":"41","author":[{"given":"Zhuoran","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piaopiao","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9395-4078","authenticated-orcid":false,"given":"Xuebing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00702-023-02702-w","volume":"131","author":"Y Li","year":"2024","unstructured":"Li Y, Yang H, Zhao P, Yang J, Yao C, Zhou C. Autophagy markers, cognitive deficits and depressive symptoms in Parkinson\u2019s disease. J Neural Transm 2024, 131: 73\u201381.","journal-title":"J Neural Transm"},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1570159X17666191016094857","volume":"18","author":"F Assogna","year":"2020","unstructured":"Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano GR, Alborghetti M, et al. Drug choices and advancements for managing depression in Parkinson\u2019s disease. Curr Neuropharmacol 2020, 18: 277\u2013287.","journal-title":"Curr Neuropharmacol"},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12888-020-02711-z","volume":"20","author":"A Revet","year":"2020","unstructured":"Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TTH. Antidepressants and movement disorders: A postmarketing study in the world pharmacovigilance database. BMC Psychiatry 2020, 20: 308.","journal-title":"BMC Psychiatry"},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.ajp.2021.102691","volume":"61","author":"DQ Jiang","year":"2021","unstructured":"Jiang DQ, Jiang LL, Wang Y, Li MX. The role of pramipexole in the treatment of patients with depression and Parkinson\u2019s disease: A meta-analysis of randomized controlled trials. Asian J Psychiatr 2021, 61: 102691.","journal-title":"Asian J Psychiatr"},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/jrms.jrms_790_21","volume":"27","author":"E Ziaei","year":"2022","unstructured":"Ziaei E, Emami Ardestani P, Chitsaz A. Comparison of pramipexole and citalopram in the treatment of depression in Parkinson\u2019s disease: A randomized parallel-group trial. J Res Med Sci 2022, 27: 55.","journal-title":"J Res Med Sci"},{"key":"1323_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn.2017.25","volume":"18","author":"S Przedborski","year":"2017","unstructured":"Przedborski S. The two-century journey of Parkinson disease research. Nat Rev Neurosci 2017, 18: 251\u2013259.","journal-title":"Nat Rev Neurosci"},{"key":"1323_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/life11080804","volume":"11","author":"L Magistrelli","year":"2021","unstructured":"Magistrelli L, Contaldi E, Comi C. The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson\u2019s disease. Life 2021, 11: 804.","journal-title":"Life"},{"key":"1323_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41398-022-01842-z","volume":"12","author":"L Miquel-Rio","year":"2022","unstructured":"Miquel-Rio L, Alarc\u00f3n-Ar\u00eds D, Torres-L\u00f3pez M, C\u00f3ppola-Segovia V, Pavia-Collado R, Paz V, et al. Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Transl Psychiatry 2022, 12: 79.","journal-title":"Rescue by oligonucleotide therapy. Transl Psychiatry"},{"key":"1323_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.18632\/aging.202189","volume":"13","author":"J Yan","year":"2020","unstructured":"Yan J, Huang J, Liu A, Wu J, Fan H, Shen M, et al. Atorvastatin improves motor function, anxiety and depression by NOX2-mediated autophagy and oxidative stress in MPTP-lesioned mice. Aging 2020, 13: 831\u2013845.","journal-title":"Aging"},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/awac261","volume":"146","author":"S Herman","year":"2023","unstructured":"Herman S, Djaldetti R, Mollenhauer B, Offen D. CSF-derived extracellular vesicles from patients with Parkinson\u2019s disease induce symptoms and pathology. Brain 2023, 146: 209\u2013224.","journal-title":"Brain"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.26453","volume":"92","author":"MR Arnold","year":"2022","unstructured":"Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM, et al. \u03b1-synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological \u03b1-synuclein in the context of co-pathology and non-LBD diagnoses. Ann Neurol 2022, 92: 650\u2013662.","journal-title":"Ann Neurol"},{"key":"1323_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2018.03.026","volume":"379","author":"B Huang","year":"2018","unstructured":"Huang B, Wu S, Wang Z, Ge L, Rizak JD, Wu J, et al. Phosphorylated \u03b1-synuclein accumulations and lewy body-like pathology distributed in Parkinson\u2019s disease-related brain areas of aged Rhesus monkeys treated with MPTP. Neuroscience 2018, 379: 302\u2013315.","journal-title":"Neuroscience"},{"key":"1323_CR13","doi-asserted-by":"crossref","unstructured":"Kasongo DW, de Leo G, Vicario N, Leanza G, Legname G. Chronic \u03b1-synuclein accumulation in rat hippocampus induces lewy bodies formation and specific cognitive impairments. eNeuro 2020, 7: ENEURO.0009\u2013ENEURO.0020.2020.","DOI":"10.1523\/ENEURO.0009-20.2020"},{"key":"1323_CR14","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/mp.2016.118","volume":"22","author":"JS Seo","year":"2017","unstructured":"Seo JS, Wei J, Qin L, Kim Y, Yan Z, Greengard P. Cellular and molecular basis for stress-induced depression. Mol Psychiatry 2017, 22: 1440\u20131447.","journal-title":"Mol Psychiatry"},{"key":"1323_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopsych.2018.09.031","volume":"85","author":"EL Belleau","year":"2019","unstructured":"Belleau EL, Treadway MT, Pizzagalli DA. The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology. Biol Psychiatry 2019, 85: 443\u2013453.","journal-title":"Biol Psychiatry"},{"key":"1323_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.neuron.2019.02.026","volume":"102","author":"H Xu","year":"2019","unstructured":"Xu H, Liu L, Tian Y, Wang J, Li J, Zheng J, et al. A disinhibitory microcircuit mediates conditioned social fear in the prefrontal cortex. Neuron 2019, 102: 668-682.e5.","journal-title":"Neuron"},{"key":"1323_CR17","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1007\/s12035-020-01941-2","volume":"57","author":"J Tang","year":"2020","unstructured":"Tang J, Lu L, Wang Q, Liu H, Xue W, Zhou T, et al. Crocin reverses depression-like behavior in parkinson disease mice via VTA-mPFC pathway. Mol Neurobiol 2020, 57: 3158\u20133170.","journal-title":"Mol Neurobiol"},{"key":"1323_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/ijnp\/pyy005","volume":"21","author":"J Wang","year":"2018","unstructured":"Wang J, Jia Y, Li G, Wang B, Zhou T, Zhu L, et al. The dopamine receptor D3 regulates lipopolysaccharide-induced depressive-like behavior in mice. Int J Neuropsychopharmacol 2018, 21: 448\u2013460.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1323_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bdi.12449","volume":"18","author":"VJ De-Paula","year":"2016","unstructured":"De-Paula VJ, Gattaz WF, Forlenza OV. Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations. Bipolar Disord 2016, 18: 692\u2013695.","journal-title":"Bipolar Disord"},{"key":"1323_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.psyneuen.2017.11.013","volume":"88","author":"H Xu","year":"2018","unstructured":"Xu H, Wang J, Zhang K, Zhao M, Ellenbroek B, Shao F, et al. Effects of adolescent social stress and antidepressant treatment on cognitive inflexibility and Bdnf epigenetic modifications in the mPFC of adult mice. Psychoneuroendocrinology 2018, 88: 92\u2013101.","journal-title":"Psychoneuroendocrinology"},{"key":"1323_CR21","doi-asserted-by":"publisher","first-page":"101905","DOI":"10.1016\/j.pneurobio.2020.101905","volume":"198","author":"EH Ahn","year":"2021","unstructured":"Ahn EH, Kang SS, Liu X, Cao X, Choi SY, Musazzi L, et al. BDNF and Netrin-1 repression by C\/EBP\u03b2 in the gut triggers Parkinson\u2019s disease pathologies, associated with constipation and motor dysfunctions. Prog Neurobiol 2021, 198: 101905.","journal-title":"Prog Neurobiol"},{"key":"1323_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuropharm.2015.08.016","volume":"99","author":"S Nie","year":"2015","unstructured":"Nie S, Xu Y, Chen G, Ma K, Han C, Guo Z, et al. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Neuropharmacology 2015, 99: 448\u2013458.","journal-title":"Neuropharmacology"},{"key":"1323_CR23","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.3390\/ijms24065945","volume":"24","author":"A de Bartolomeis","year":"2023","unstructured":"de Bartolomeis A, Ciccarelli M, De Simone G, Mazza B, Barone A, Vellucci L. Canonical and non-canonical antipsychotics\u2019 dopamine-related mechanisms of present and next generation molecules: A systematic review on translational highlights for treatment response and treatment-resistant schizophrenia. Int J Mol Sci 2023, 24: 5945.","journal-title":"Int J Mol Sci"},{"key":"1323_CR24","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s00259-023-06171-x","volume":"50","author":"Y Chahid","year":"2023","unstructured":"Chahid Y, Sheikh ZH, Mitropoulos M, Booij J. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using[123I]I-FP-CIT SPECT in routine practice. Eur J Nucl Med Mol Imaging 2023, 50: 1974\u20131987.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1323_CR25","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"MY Liu","year":"2018","unstructured":"Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, Luo CX, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 2018, 13: 1686\u20131698.","journal-title":"Nat Protoc"},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","volume":"77","author":"MJ Primo","year":"2023","unstructured":"Primo MJ, Fonseca-Rodrigues D, Almeida A, Teixeira PM, Pinto-Ribeiro F. Sucrose preference test: A systematic review of protocols for the assessment of anhedonia in rodents. Eur Neuropsychopharmacol 2023, 77: 80\u201392.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1323_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","volume":"8","author":"KG Commons","year":"2017","unstructured":"Commons KG, Cholanians AB, Babb JA, Ehlinger DG. The rodent forced swim test measures stress-coping strategy, not depression-like behavior. ACS Chem Neurosci 2017, 8: 955\u2013960.","journal-title":"ACS Chem Neurosci"},{"key":"1323_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2021.06.014","volume":"128","author":"A Armario","year":"2021","unstructured":"Armario A. The forced swim test: Historical, conceptual and methodological considerations and its relationship with individual behavioral traits. Neurosci Biobehav Rev 2021, 128: 74\u201386.","journal-title":"Neurosci Biobehav Rev"},{"key":"1323_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1017\/S1092852921000729","volume":"27","author":"MH Huang","year":"2022","unstructured":"Huang MH, Chen MH, Hsu JW, Huang KL, Tsai SJ, Su TP, et al. Inflammation, cognitive dysfunction, and suicidal ideation among patients with major depression. CNS Spectr 2022, 27: 724\u2013730.","journal-title":"CNS Spectr"},{"key":"1323_CR30","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1017\/S0033291722003671","volume":"53","author":"F Matcham","year":"2023","unstructured":"Matcham F, Simblett SK, Leightley D, Dalby M, Siddi S, Haro JM, et al. The association between persistent cognitive difficulties and depression and functional outcomes in people with major depressive disorder. Psychol Med 2023, 53: 6334\u20136344.","journal-title":"Psychol Med"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"e0156589","DOI":"10.1371\/journal.pone.0156589","volume":"11","author":"T Lucon-Xiccato","year":"2016","unstructured":"Lucon-Xiccato T, Dadda M. Guppies show behavioural but not cognitive sex differences in a novel object recognition test. PLoS One 2016, 11: e0156589.","journal-title":"PLoS One"},{"key":"1323_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/scan\/nss084","volume":"8","author":"P Taurisano","year":"2013","unstructured":"Taurisano P, Blasi G, Romano R, Sambataro F, Fazio L, Gelao B, et al. DAT by perceived MC interaction on human prefrontal activity and connectivity during emotion processing. Soc Cogn Affect Neurosci 2013, 8: 855\u2013862.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"1323_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12017-023-08755-0","volume":"25","author":"Y Liang","year":"2023","unstructured":"Liang Y, Zhong G, Ren M, Sun T, Li Y, Ye M, et al. The role of ubiquitin-proteasome system and mitophagy in the pathogenesis of Parkinson\u2019s disease. Neuromolecular Med 2023, 25: 471\u2013488.","journal-title":"Neuromolecular Med"},{"key":"1323_CR34","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1038\/s41467-023-44033-0","volume":"14","author":"N Furthmann","year":"2023","unstructured":"Furthmann N, Bader V, Angersbach L, Blusch A, Goel S, S\u00e1nchez-Vicente A, et al. NEMO reshapes the \u03b1-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62. Nat Commun 2023, 14: 8368.","journal-title":"Nat Commun"},{"key":"1323_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1074\/jbc.M111.288449","volume":"287","author":"TM Durcan","year":"2012","unstructured":"Durcan TM, Kontogiannea M, Bedard N, Wing SS, Fon EA. Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme. J Biol Chem 2012, 287: 531\u2013541.","journal-title":"J Biol Chem"},{"key":"1323_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neulet.2018.11.043","volume":"702","author":"S Huang","year":"2019","unstructured":"Huang S, Borgland SL, Zamponi GW. Dopaminergic modulation of pain signals in the medial prefrontal cortex: Challenges and perspectives. Neurosci Lett 2019, 702: 71\u201376.","journal-title":"Neurosci Lett"},{"key":"1323_CR37","doi-asserted-by":"publisher","first-page":"S497","DOI":"10.1002\/mds.22028","volume":"23","author":"S Fahn","year":"2008","unstructured":"Fahn S. The history of dopamine and levodopa in the treatment of Parkinson\u2019s disease. Mov Disord 2008, 23: S497\u2013S508.","journal-title":"Mov Disord"},{"key":"1323_CR38","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, Benskey MJ, Cao X, et al. TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 2017, 114: 10773\u201310778.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1323_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila N, Bhurtel S, Shadfar S, Srivastav S, Neupane S, Ojha U, et al. Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 2017, 125: 396\u2013407.","journal-title":"Neuropharmacology"},{"key":"1323_CR40","doi-asserted-by":"publisher","first-page":"18430","DOI":"10.1073\/pnas.1115907108","volume":"108","author":"PL Cheng","year":"2011","unstructured":"Cheng PL, Song AH, Wong YH, Wang S, Zhang X, Poo MM. Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci U S A 2011, 108: 18430\u201318435.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1323_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1095\/biolreprod.114.127027","volume":"92","author":"LA McGinnis","year":"2015","unstructured":"McGinnis LA, Lee HJ, Robinson DN, Evans JP. MAPK3\/1 (ERK1\/2) and myosin light chain kinase in mammalian eggs affect myosin-II function and regulate the metaphase II state in a calcium- and zinc-dependent manner. Biol Reprod 2015, 92: 146.","journal-title":"Biol Reprod"},{"key":"1323_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s12264-019-00367-8","volume":"35","author":"Y Li","year":"2019","unstructured":"Li Y, Liu J, Liu X, Su CJ, Zhang QL, Wang ZH, et al. Antidepressant-like action of single facial injection of botulinum neurotoxin A is associated with augmented 5-HT levels and BDNF\/ERK\/CREB pathways in mouse brain. Neurosci Bull 2019, 35: 661\u2013672.","journal-title":"Neurosci Bull"},{"key":"1323_CR43","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1007\/s12035-019-1524-3","volume":"56","author":"JQ Wang","year":"2019","unstructured":"Wang JQ, Mao L. The ERK pathway: Molecular mechanisms and treatment of depression. Mol Neurobiol 2019, 56: 6197\u20136205.","journal-title":"Mol Neurobiol"},{"key":"1323_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1042\/BJ20131115","volume":"458","author":"S Naqvi","year":"2014","unstructured":"Naqvi S, Martin KJ. CREB phosphorylation at Ser133 regulates transcription via distinct mechanisms downstream of cAMP and MAPK signalling. Biochem J 2014, 458: 469\u2013479.","journal-title":"Biochem J"},{"key":"1323_CR45","first-page":"1286","volume":"11","author":"XY Meng","year":"2021","unstructured":"Meng XY, Zhang HZ, Ren YY, Wang KJ, Chen JF, Su R, et al. Pinin promotes tumor progression via activating CREB through PI3K\/AKT and ERK\/MAPK pathway in prostate cancer. Am J Cancer Res 2021, 11: 1286\u20131303.","journal-title":"Am J Cancer Res"},{"key":"1323_CR46","doi-asserted-by":"publisher","first-page":"1014840","DOI":"10.3389\/fphar.2022.1014840","volume":"13","author":"ME Pak","year":"2022","unstructured":"Pak ME, Yang HJ, Li W, Kim JK, Go Y. Yuk-Gunja-Tang attenuates neuronal death and memory impairment via ERK\/CREB\/BDNF signaling in the hippocampi of experimental Alzheimer\u2019s disease model. Front Pharmacol 2022, 13: 1014840.","journal-title":"Front Pharmacol"},{"key":"1323_CR47","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/biom12060802","volume":"12","author":"M Yang","year":"2022","unstructured":"Yang M, Lu Y, Piao W, Jin H. The translational regulation in mTOR pathway. Biomolecules 2022, 12: 802.","journal-title":"Biomolecules"},{"key":"1323_CR48","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","volume":"18","author":"M Morita","year":"2013","unstructured":"Morita M, Gravel SP, Ch\u00e9nard V, Sikstr\u00f6m K, Zheng L, Alain T, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab 2013, 18: 698\u2013711.","journal-title":"Cell Metab"},{"key":"1323_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12264-022-00898-7","volume":"39","author":"X Ke","year":"2023","unstructured":"Ke X, Deng M, Wu Z, Yu H, Yu D, Li H, et al. MiR-34b-3p inhibition of eIF4E causes post-stroke depression in adult mice. Neurosci Bull 2023, 39: 194\u2013212.","journal-title":"Neurosci Bull"},{"key":"1323_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejphar.2017.09.029","volume":"815","author":"V Silva Pereira","year":"2017","unstructured":"Silva Pereira V, Elfving B, Joca SRL, Wegener G. Ketamine and aminoguanidine differentially affect Bdnf and Mtor gene expression in the prefrontal cortex of adult male rats. Eur J Pharmacol 2017, 815: 304\u2013311.","journal-title":"Eur J Pharmacol"},{"key":"1323_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry 2018, 23: 801\u2013811.","journal-title":"Mol Psychiatry"},{"key":"1323_CR52","doi-asserted-by":"publisher","first-page":"e77455","DOI":"10.7554\/eLife.77455","volume":"12","author":"G Moya-Alvarado","year":"2023","unstructured":"Moya-Alvarado G, Tiburcio-Felix R, Ib\u00e1\u00f1ez MR, Aguirre-Soto AA, Guerra MV, Wu C, et al. BDNF\/TrkB signaling endosomes in axons coordinate CREB\/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons. Elife 2023, 12: e77455.","journal-title":"Elife"},{"key":"1323_CR53","doi-asserted-by":"publisher","first-page":"e27160","DOI":"10.1016\/j.heliyon.2024.e27160","volume":"10","author":"M Omi","year":"2024","unstructured":"Omi M, Yamada H, Takahashi H, Mori H, Oba S, Hattori Y, et al. Differences in collateral vessel formation after experimental retinal vein occlusion in spontaneously hypertensive rats and wild-type rats. Heliyon 2024, 10: e27160.","journal-title":"Heliyon"},{"key":"1323_CR54","doi-asserted-by":"publisher","first-page":"111150","DOI":"10.1016\/j.intimp.2023.111150","volume":"125","author":"T Yang","year":"2023","unstructured":"Yang T, Li L, Pang J, Heng C, Wei C, Wang X, et al. Modulating intestinal barrier function by sphingosine-1-phosphate receptor 1 specific agonist SEW2871 attenuated ANIT-induced cholestatic hepatitis via the gut-liver axis. Int Immunopharmacol 2023, 125: 111150.","journal-title":"Int Immunopharmacol"},{"key":"1323_CR55","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1139\/cjpp-2021-0006","volume":"99","author":"D Zhang","year":"2021","unstructured":"Zhang D, Qi D, Xu Y, Hu C, Zhang X, Yang Q, et al. The S1PR1 agonist SEW2871 promotes the survival of skin flap. Can J Physiol Pharmacol 2021, 99: 1280\u20131287.","journal-title":"Can J Physiol Pharmacol"},{"key":"1323_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2020.00077","volume":"11","author":"\u00c9 P\u00e9pin","year":"2020","unstructured":"P\u00e9pin \u00c9, Jalinier T, Lemieux GL, Massicotte G, Cyr M. Sphingosine-1-phosphate receptors modulators decrease signs of neuroinflammation and prevent Parkinson\u2019s disease symptoms in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model. Front Pharmacol 2020, 11: 77.","journal-title":"Front Pharmacol"},{"key":"1323_CR57","first-page":"449","volume":"12","author":"M Asle-Rousta","year":"2013","unstructured":"Asle-Rousta M, Oryan S, Ahmadiani A, Rahnema M. Activation of sphingosine 1-phosphate receptor-1 by SEW2871 improves cognitive function in Alzheimer\u2019s disease model rats. EXCLI J 2013, 12: 449\u2013461.","journal-title":"EXCLI J"},{"key":"1323_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.brainres.2017.01.014","volume":"1658","author":"F St-Cyr Gigu\u00e8re","year":"2017","unstructured":"St-Cyr Gigu\u00e8re F, Attiori Essis S, Chagniel L, Germain M, Cyr M, Massicotte G. The sphingosine-1-phosphate receptor 1 agonist SEW2871 reduces Tau-Ser262 phosphorylation in rat hippocampal slices. Brain Res 2017, 1658: 51\u201359.","journal-title":"Brain Res"},{"key":"1323_CR59","doi-asserted-by":"publisher","first-page":"111013","DOI":"10.1016\/j.pnpbp.2024.111013","volume":"133","author":"L Miguel Telega","year":"2024","unstructured":"Miguel Telega L, Berti R, Blazhenets G, Domogalla LC, Steinacker N, Omrane MA, et al. Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation. Prog Neuropsychopharmacol Biol Psychiatry 2024, 133: 111013.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1323_CR60","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/cells10071694","volume":"10","author":"DK Verma","year":"2021","unstructured":"Verma DK, Seo BA, Ghosh A, Ma SX, Hernandez-Quijada K, Andersen JK, et al. Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson\u2019s disease models. Cells 2021, 10: 1694.","journal-title":"Cells"},{"key":"1323_CR61","doi-asserted-by":"publisher","first-page":"e2103396","DOI":"10.1002\/advs.202103396","volume":"9","author":"G Chen","year":"2022","unstructured":"Chen G, Ahn EH, Kang SS, Xia Y, Liu X, Zhang Z, et al. UNC5C receptor proteolytic cleavage by active AEP promotes dopaminergic neuronal degeneration in Parkinson\u2019s disease. Adv Sci 2022, 9: e2103396.","journal-title":"Adv Sci"},{"key":"1323_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","volume":"109","author":"G Bieri","year":"2018","unstructured":"Bieri G, Gitler AD, Brahic M. Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Neurobiol Dis 2018, 109: 219\u2013225.","journal-title":"Neurobiol Dis"},{"key":"1323_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00018-022-04595-6","volume":"79","author":"R Ashraf","year":"2022","unstructured":"Ashraf R, Kumar S. Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK\/mTOR\/ERK signaling. Cell Mol Life Sci 2022, 79: 573.","journal-title":"Cell Mol Life Sci"},{"key":"1323_CR64","doi-asserted-by":"publisher","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","volume":"257","author":"M Amidfar","year":"2020","unstructured":"Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK. The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease. Life Sci 2020, 257: 118020.","journal-title":"Life Sci"},{"key":"1323_CR65","doi-asserted-by":"publisher","first-page":"108990","DOI":"10.1016\/j.neuropharm.2022.108990","volume":"209","author":"P Tan","year":"2022","unstructured":"Tan P, Xue T, Wang Y, Hu Z, Su J, Yang R, et al. Hippocampal NR6A1 impairs CREB-BDNF signaling and leads to the development of depression-like behaviors in mice. Neuropharmacology 2022, 209: 108990.","journal-title":"Neuropharmacology"},{"key":"1323_CR66","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/glia.23760","volume":"68","author":"Y Hu","year":"2020","unstructured":"Hu Y, Mai W, Chen L, Cao K, Zhang B, Zhang Z, et al. mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP. Glia 2020, 68: 1031\u20131045.","journal-title":"Glia"},{"key":"1323_CR67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/cei.12304","volume":"177","author":"J Dong","year":"2014","unstructured":"Dong J, Wang H, Wu G, Zhao J, Zhang L, Zuo L, et al. Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice. Clin Exp Immunol 2014, 177: 94\u2013101.","journal-title":"Clin Exp Immunol"},{"key":"1323_CR68","doi-asserted-by":"publisher","first-page":"e49405","DOI":"10.7554\/eLife.49405","volume":"8","author":"M Mathiesen Janiurek","year":"2019","unstructured":"Mathiesen Janiurek M, Soylu-Kucharz R, Christoffersen C, Kucharz K, Lauritzen M. Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis. Elife 2019, 8: e49405.","journal-title":"Elife"},{"key":"1323_CR69","first-page":"1763","volume":"18","author":"LX Yang","year":"2023","unstructured":"Yang LX, Yao YY, Yang JR, Cheng HL, Zhu XJ, Zhang ZJ. Sphingosine 1-phosphate receptor 1 regulates blood-brain barrier permeability in epileptic mice. Neural Regen Res 2023, 18: 1763\u20131769.","journal-title":"Neural Regen Res"},{"key":"1323_CR70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2022.05.025","volume":"187","author":"MC Chiang","year":"2022","unstructured":"Chiang MC, Nicol CJB. GSH-AuNP anti-oxidative stress, ER stress and mitochondrial dysfunction in amyloid-beta peptide-treated human neural stem cells. Free Radic Biol Med 2022, 187: 185\u2013201.","journal-title":"Free Radic Biol Med"},{"key":"1323_CR71","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1039\/D1NR01415C","volume":"13","author":"ZH Zhang","year":"2021","unstructured":"Zhang ZH, Hu J, Chen Q, Chen J, Hu X, Koh K, et al. The magnetic-nanoparticle-assisted sensitive detection of nitrated \u03b1-syn in blood based on a sensitizing electrochemical layer. Nanoscale 2021, 13: 8107\u20138117.","journal-title":"Nanoscale"},{"key":"1323_CR72","doi-asserted-by":"publisher","first-page":"60894","DOI":"10.1021\/acsami.1c18754","volume":"13","author":"D Wahyuningtyas","year":"2021","unstructured":"Wahyuningtyas D, Chen WH, He RY, Huang YA, Tsao CK, He YJ, et al. Polyglutamine-specific gold nanoparticle complex alleviates mutant huntingtin-induced toxicity. ACS Appl Mater Interfaces 2021, 13: 60894\u201360906.","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-024-01323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-024-01323-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-024-01323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T12:02:16Z","timestamp":1749643336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-024-01323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1007\/s12264-024-01323-x","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"We confirm that all our animal experiments conformed to the Guidelines of Laboratory Animals Ethics of Huazhong University of Science and Technology and were approved by the Institutional Animal Care and Use Committee at Huazhong University of Science and Technology, China (IACUC number: 2592).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}